SCHEMBL26123745

SCHEMBL26123745

Cc1c(Br)ccc2c1C(O)OC2=O

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.32
P2RX3 P56373 1/20 0.30
AKT1 P31749 1/20 0.30
PTPRF P10586 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30546467 1.00 AR (0.32) ARP2RX3AKT1PTPRF
SCHEMBL26123423 0.84 ACHE (0.33) AKT1
SCHEMBL22345863 0.82 PTPRF (0.36) ARPTPRF
SCHEMBL20168433 0.81 AKT1 (0.45) AKT1
SCHEMBL26123929 0.81 AKT1 (0.34) P2RX3AKT1
SCHEMBL24329423 0.79
SCHEMBL21617656 0.79
SCHEMBL29582879 0.79
SCHEMBL26921579 0.79 ALDH1A1 (0.33)
SCHEMBL26126323 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192989-A2 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS AZKARRA THERAPEUTICS, INC. (US) 2023-10-05 WO disclosed
WO-2023192989-A2 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS AZKARRA THERAPEUTICS, INC. (US) 2023-10-05 WO disclosed